AXXELENT PHARMA SCIENCE PRIVATE LIMITED having CIN U24110TN2019PTC131943 is 5 years , 8 month & 15 days old Private Indian Company incorporated on 07 Oct 2019. It is classified as Non-government company and is registered at ROC Chennai. Its authorized share capital is Rs. 1,400,000,000 and its paid up capital is Rs. 1,277,381,840. It's NIC code is 24110 (which is part of its CIN).
As per the NIC code, it is involved in . AXXELENT PHARMA SCIENCE Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 07-10-2023. Directors of AXXELENT PHARMA SCIENCE are Kamlesh Phulwani and Kamlesh Phulwani.
AXXELENT PHARMA SCIENCE ' Corporate Identification Number (CIN) is U24110TN2019PTC131943 and its registration number is 131943. Users may contact AXXELENT PHARMA SCIENCE on its Email address - soundarya@axxelent.com Registered address of AXXELENT PHARMA SCIENCE is No. 3 Jagadeeswaran Street,Chennai,Tamil Nadu,India-600017. Current status of AXXELENT PHARMA SCIENCE PRIVATE LIMITED is - Active.
as on 22/06/2025
as on 22/06/2025
CIN | U24110TN2019PTC131943 |
---|---|
Company Status | Active |
Registration Number | 131943 |
Date of Incorporation | 10/07/2019 |
RoC | ROC Chennai |
Company Age | 5 years & 260 days |
Authorized Capital | ₹ 1400000000 |
Paid-up capital | ₹ 1277381840 |
Company Category | Company limited by shares |
Company Sub-Category | Non-government company |
Class of company | Private |
Activity | |
Listing status | Unlisted |
Date of Last Annual General Meeting | 31-03-2023 |
Date of Latest Balance Sheet | 31-03-2023 |
Email ID | soundarya@axxelent.com |
---|---|
Address | No. 3 Jagadeeswaran Street Chennai Tamil Nadu India 600017 |
Website | axxelent.com |
Contact Number | +91******* |
DIN | Name | Date OF Appointment | Designation | Tenure |
---|---|---|---|---|
08565891 | 27 Mar 2023 | Director | 5 years | |
05297969 | 29 Mar 2023 | Director | 5 years | |
06776403 | 23 Mar 2023 | Director | 5 years | |
08151291 | 14 Feb 2023 | Director | 5 years | |
06469234 | 24 Jan 2023 | Director | 5 years | |
08955389 | 04 Dec 2020 | Director | 5 years | |
00050440 | 07 Oct 2019 | Director | 5 years | |
03100409 | 05 May 2023 | Director | 5 years |
Name | Status | Paid Up Capital | Common Directors | Address |
---|---|---|---|---|
Strike Off
|
10,00,000.00 | 2 | Tamil Nadu | |
Strike Off
|
1,00,000.00 | 2 | Tamil Nadu | |
87,00,000.00 | 2 | Tamil Nadu | ||
1,50,000.00 | 2 | Tamil Nadu | ||
0.00 | 2 | - | ||
40,25,38,312.50 | 2 | Maharashtra | ||
Amalgamated
|
5,08,750.00 | 1 | Tamil Nadu | |
Strike Off
|
1,00,030.00 | 1 | Telangana | |
Converted to LLP
|
1,55,00,000.00 | 1 | Tamil Nadu |
HDFC BANK LIMITED
No. of Loans: 2
Total Amount: 1,759,577,000.00 cr
Charge Holder | Branch | Amount | Date of creation | Modification | Satisfaction | Status |
---|---|---|---|---|---|---|
HDFC BANK LIMITED | Mumbai | 2,458,000 | 13 Dec, 2023 | - | - | Open |
HDFC BANK LIMITED | LOWER PAREL W | 1,757,119,000 | 30 Sep, 2020 | 29 Nov, 2022 | - | Open |
* There is the date provided by MCA, but availability for this year is not guaranteed.
** All rupee values in INR crores. Based on March 2024 numbers.
** All numbers in INR
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales |
|
|
|
|
|
Operating profit |
|
|
|
|
|
Net profit |
|
|
|
|
|
Gross margin |
|
|
|
|
|
Operating margin |
|
|
|
|
|
Net margin |
|
|
|
|
|
Networth |
|
|
|
|
|
Borrowings |
|
|
|
|
|
Assets |
|
|
|
|
|
Debt to equity |
|
|
|
|
|
Current ratio |
|
|
|
|
|
ROE |
|
|
|
|
|
Days payable |
|
|
|
|
|
WC days |
|
|
|
|
|
**** All numbers in INR
Mar 2020
|
Mar 2021
|
Mar 2022
|
Mar 2023
|
Mar 2024
|
|
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
(1) Shareholders‘ funds | |
|
|
|
|
(a) Share capita | |
|
|
|
|
(b) Reserves and surplus | |
|
|
|
|
(c) Money received against share warrants | |
|
|
|
|
(2) Share application money pending allotment | |
|
|
|
|
(3) Non-current liabilities | |
|
|
|
|
(a) Long-term borrowings | |
|
|
|
|
(b) Deferred tax liabilities (Net) | |
|
|
|
|
(c) Other Long-term liabilities | |
|
|
|
|
(d) Long-term provisions | |
|
|
|
|
(4) Current liabilities | |
|
|
|
|
(a) Short-term borrowings | |
|
|
|
|
(b) Trade payables | |
|
|
|
|
(A) total outstanding dues of micro enterprises and small enterprises; and | |
|
|
|
|
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. | |
|
|
|
|
(c) Other current liabilities | |
|
|
|
|
(d) Short-term provisions | |
|
|
|
|
Total | |
|
|
|
|
ASSETS | |||||
Non-current assets | |
|
|
|
|
(a) [Property, Plant and Equipment] | |
|
|
|
|
(i) Tangible assets | |
|
|
|
|
(ii) Intangible assets | |
|
|
|
|
(iii)Capital work-in-progress | |
|
|
|
|
(iv) Intangible assets under development | |
|
|
|
|
(b) Non-current investments | |
|
|
|
|
(c) Deferred tax assets (net) | |
|
|
|
|
(d) Long-term loans and advances | |
|
|
|
|
(e) Other non-current assets | |
|
|
|
|
(2) Current assets | |
|
|
|
|
(a) Current investments | |
|
|
|
|
(b) Inventories | |
|
|
|
|
(c) Trade receivables | |
|
|
|
|
(d) Cash and cash equivalents | |
|
|
|
|
(e) Short-term loans and advances | |
|
|
|
|
(f) Other current assets | |
|
|
|
|
Total assets | |
|
|
|
|
EQUITY AND LIABILITIES | ||||
(1) Shareholders‘ funds | ||||
(a) Share capital | ||||
(b) Reserves and surplus | ||||
(c) Money received against share warrants | ||||
(2) Share application money pending allotment | ||||
(3) Non-current liabilities | ||||
(a) Long-term borrowings | ||||
(b) Deferred tax liabilities (Net) | ||||
(c) Other Long-term liabilities | ||||
(d) Long-term provisions | ||||
(4) Current liabilities | ||||
(a) Short-term borrowings | ||||
(b) Trade payables | ||||
(A) total outstanding dues of micro enterprises and small enterprises; and | ||||
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. | ||||
(c) Other current liabilities | ||||
(d) Short-term provisions | ||||
Total | ||||
ASSETS | ||||
Non-current assets | ||||
(a) [Property, Plant and Equipment] | ||||
(i) Tangible assets | ||||
(ii) Intangible assets | ||||
(iii)Capital work-in-progress | ||||
(iv) Intangible assets under development | ||||
(b) Non-current investments | ||||
(c) Deferred tax assets (net) | ||||
(d) Long-term loans and advances | ||||
(e) Other non-current assets | ||||
(2) Current assets | ||||
(a) Current investments | ||||
(b) Inventories | ||||
(c) Trade receivables | ||||
(d) Cash and cash equivalents | ||||
(e) Short-term loans and advances | ||||
(f) Other current assets | ||||
Total assets |
**** All numbers in INR
Precentage of total incomex |
---|
** All numbers in INR
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt/Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liquidity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Performance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Return | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Return on Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pre-tax ROCE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Return on Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pre-tax ROIC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Efficiency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Working Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Working Capital Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Date of Filing | Date of Dispatch of Notice | Date of Passing Resolution | Section (Companies Act 2013) | Purpose of passing the resolution | Subject Matter of Resolution | Resolution Agreed By | Special Resolution | Address |
---|
Financial Year | Name of Auditor or Firm | PAN of Auditor or Firm | Membership Number | Registration Number | Address |
---|
Director Complain
AXXELENT PHARMA SCIENCE PRIVATE LIMITED having CIN U24110TN2019PTC131943 is 5 years , 8 month old Private Indian Company incorporated with MCA on 05 May 2023. AXXELENT PHARMA SCIENCE PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Chennai with an Authorized Share Capital of 1,400,000,000 and paid-up capital is 1,277,381,840.
CIN of AXXELENT PHARMA SCIENCE PRIVATE LIMITED is U24110TN2019PTC131943.
Address of AXXELENT PHARMA SCIENCE PRIVATE LIMITED is No. 3 jagadeeswaran street,chennai,tamil nadu,india-600017,.
The company has 16 directors/key management personnel Sampath Devarajan,subramanian Hariharan,. Chaitanya Devendra,punnaivanam Harihara Ponnambalam,jagannathan Soundarya,u24110tn2019ptc131943 U24110tn2019ptc131943,punnaivanam Harihara Ponnambalam,jitesh Devendra,jitesh Devendra,sreenivasa Bhimanatham,shankarlal Devendra .,sampath Devarajan,. Chaitanya Devendra,subramanian Hariharan,kamlesh Phulwani,kamlesh Phulwani,
Email : soundarya@axxelent.com
Address : No. 3 Jagadeeswaran Street Chennai Tamil Nadu India 600017
AXXELENT PHARMA SCIENCE PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities